The center integrates the work of faculty, trainees and staff. Gene Morse is the center director and works closely with a scientific leadership committee and an advisory board.
Gene Morse also directs the Translational Pharmacology Research Core in UB's New York State Center of Excellence in Bioinformatics and Life Sciences. He has been actively involved in drug development research since the introduction of antiretrovirals for HIV in 1986, with more recent emphasis on HCV infection and antiviral drug development.
He is the principal Investigator for the NIH Fogarty International Center, HIV Research Training Program with the University of Zimbabwe, co-chair of the SUNY-University of the West Indies Faculty Task Force for Health Research Development and chair of the Buffalo Jamaica Innovation Enterprise Executive Committee. Morse is the hub steward for the Western New York Science, Technology, Engineering and Mathematics (STEM) Hub.
Terrence Forrester holds fellowships in the Royal College of Physicians of both London and Edinburgh and is a professor of experimental medicine at the University of the West Indies Mona Campus.
His research focuses on risks and impacts of obesity, metabolic programming of early life and the constraints of fetal growth, and understanding the economic implications of chronic diseases and their intervention. He spearheaded the formation of the Tropical Medical Research Institute, which unified four research units—the Tropical Metabolic Research Unit, the Sickle Cell Research Unit, the Epidemiology Research Unit at Mona, Jamaica, and the Chronic Disease Research Unit in Barbados—across three campuses of the University of the West Indies.
James Hakim is a professor of medicine at the University of Zimbabwe in the College of Health Sciences, and is a cardiologist with more than 20 years of experience conducting clinical trials. He is the leader of the University of Zimbabwe Parirenyatwa Clinical Research Site and is an active member of the NIH AIDS Clinical Trials Group network. Professor Hakim has served as a member of the Scientific Agenda Steering Committee, Antiretroviral Committee and HPTN Executive Committee.
John Lindo also is a consultant parasitologist to the University Hospital of West Indies. Professor Lindo is co-chair of the SUNY-University of the West Indies Faculty Task Force for Health Research Development. His research has focused on the epidemiology of soil-transmitted helminths and emerging infectious diseases. This includes the epidemiology of strongyloides stercoralis infections and toxocariasis, the emergence of malaria and angiostrongylus cantonensis infections in Jamaica, epidemiology of free-living amoebae in Jamaica and opportunistic parasitic infections in persons living with HIV/AIDS.
Charles Chiedza Maponga also holds a visiting faculty position with the UB School of Pharmacy and Pharmaceutical Sciences. He travels frequently between UB and the University of Zimbabwe while coordinating the activities of an international collaborative program, the International Pharmacotherapy Education and Research Initiative. Professor Maponga is the University of Zimbabwe's principal investigator for the NIH Fogarty International Center HIV Research Training program. He works to implement a postgraduate and postdoctoral training initiative between the two universities with an emphasis on HIV clinical pharmacology.
Timothy Murphy is a SUNY distinguished professor and senior associate dean for Clinical and Translational Research in UB's Jacobs School of Medicine and Biomedical Sciences. He oversees strategies to transform UB’s research programs into new or improved treatments for patients as well as assisting faculty and trainees at all levels with their research activities. He directs the school's Clinical and Translational Research Center, located on the Buffalo Niagara Medical Campus that includes a nine-bed clinical research center with support services for clinical research. He focuses on infectious diseases.
Paras Prasad also holds the Samuel P. Capen Chair at UB and is the executive director of the multidisciplinary Institute for Lasers, Photonics and Biophotonics. He has published more than 700 scientific papers, co-edited six books and co-authored a monograph (with D.J. Williams) "Introduction to Nonlinear Optical Effects in Molecules and Polymers." Professor Prasad published "Introduction to Biophotonics," the first monograph in this field, which authoritatively defines the field, details its scope and identifies emerging opportunities. He also has published the monograph, "Nanophotonics" and "Introduction to Nanomedicine and Nanobioengineering."
Stanley Schwartz is working to develop unique therapies for treatment of metastatic prostate cancer and chronic viral infections involving the brain. The processes include nanotechnology, as well as allergy and immunology, proteins, metalloenzymes and RNA.
Andrew Talal conducts clinical and translational research in viral hepatitis. He studies viral decay and the concentrations of drugs in the liver. He directs the Center for Clinical Care and Research in Liver Disease at UB’s Clinical and Translational Research Center. His lab has received multi-year funding for its research programs. It has developed techniques for animal and human liver sampling that enable sorting of liver cells in order to understand drug distribution in the liver during treatment.